Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment
Open Access
- 21 August 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 21 (12) , 3096-3102
Abstract
BACKGROUND: Regulation of tissue remodelling and ovarian permeability by intercellular adhesion complexes may be involved in normal and pathological ovarian function. Therefore, the occurrence, distribution and hormonal control of the adherens junction protein vascular endothelial cadherin (VE-cadherin) and the tight junction proteins occludin and claudin in the human corpus luteum (CL) were investigated. METHODS: CLs from patients undergoing hysterectomy for benign reasons were enucleated during early, mid- and late stages of the functional luteal phase and after HCG rescue in vivo. Immunostaining for occludin, claudins 1 and 5 and VE-cadherin was carried out on fixed tissue. Endothelial cells, granulosa lutein cells and theca lutein cells were identified by reference to serial sections immunostained for CD34, 17α-hydroxylase and 3β-hydroxy-steroid-dehydrogenase. Quantitative analyses were performed using image analyses. RESULTS: Occludin was localized to the plasma membrane of granulosa lutein cells and endothelial cells but was absent in theca lutein cells. Claudin 1 was exclusively localized to the plasma membrane of steroidogenic cells. Claudin 5 and VE-cadherin were only present in endothelial cells. After HCG administration in vivo, adherens and tight junction proteins were significantly down-regulated (P < 0.05). CONCLUSIONS: The decrease of junctional proteins after HCG treatment suggests a hormonal control of tight and adherens junctions in the CL associated with tissue remodelling and an increase in luteal permeability during early pregnancy.Keywords
This publication has 34 references indexed in Scilit:
- Vascular Endothelial Growth Factor Trap Suppresses Ovarian Function at All Stages of the Luteal Phase in the MacaqueThe Journal of Clinical Endocrinology & Metabolism, 2005
- Ovarian hyperstimulation syndromeCritical Care Medicine, 2005
- Vascular morphogenesis in the primate ovaryAngiogenesis, 2005
- Localization and Quantification of Cyclic Changes in the Expression of Endocrine Gland Vascular Endothelial Growth Factor in the Human Corpus LuteumThe Journal of Clinical Endocrinology & Metabolism, 2005
- Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular HomeostasisPhysiological Reviews, 2004
- Endothelial cell–cell junctions: happy togetherNature Reviews Molecular Cell Biology, 2004
- Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctionsExperimental Cell Research, 2004
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndromeMolecular Human Reproduction, 2002
- Pregnancy: Luteinizing hormone receptor in the human corpus luteum: lack of down-regulation during maternal recognition of pregnancyHuman Reproduction, 1996